Friday 6 November 2026 Export RVPH’s income statement to Excel — free account

Reviva Pharmaceuticals Holdings, Inc.

RVPH Healthcare Biotechnology

EPS: +92.1%
Free cash flow: +57.8%

Quarter to June 2026, against a year earlier

0.37 0.03 +8.82%

Follow RVPH

Alert me

Market cap: $5.0M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	837.84%	(419.97%)	(256.20%)	(176.60%)
ROA Full definition →		(207.23%)	(126.42%)	(108.55%)	(79.46%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(602.91%)	(253.77%)	(95.34%)	(85.63%)
Free Cash Flow per Share Full definition →		(7.68)	(6.78)	(2.88)	(1.31)
Free Cash Flow Full definition →		(27.90)	(24.59)	(20.20)	(17.30)
Other line items
Cash ROIC Full definition →		(157.32%)	(106.53%)	(50.97%)	(49.30%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →		(967.32)	(1,507.46)	(1,992.21)	(2,042.17)
Operating CF/Net income Full definition →		1.23	1.24	1.21	1.33
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(7.68)	(6.78)	(2.88)	(1.31)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026